Forschung & Innovation
Publikationen
Durvalumab prolongs overall survival whereas radiation dose escalation >66 Gy improves long-term local control in unresectable NSCLC stage III: Updated analysis of the Austrian radio-oncological lung cancer study association registry (ALLSTAR)
PMU Autor*innen
Franz Zehentmayr, Elvis Ruznic, Brane Grambozov
Alle Autor*innen
Franz Zehentmayr, Petra Feurstein, Elvis Ruznic, Brigitte Langer, Brane Grambozov, Marissa Klebermass, Ayurzana Purevdorj, Georg Gruber, Danijela Minasch, Martin Heilmann, B. Breitfelder, Claudia Steffal, Gisela Gastinger-Grass, Karoline Kirchhammer, M. Kazil, Heidi Stranzl, Karin Dieckmann
Fachzeitschrift
JOURNAL OF THORACIC ONCOLOGY